Final results of the dose escalation phase of a phase I pharmacokinetics (PK), pharmacodynamic (PD) and biological activity study of ZD1839: NCIC CTG Ind.122 [abstract 355] - Goss,G.D.; Hirte,H.; Lorimer,I. (Proc Am Soc Clin Oncol, 2001)